Introduction {#S1}
============

*Vibrio cholerae* is a Gram-negative bacterium that naturally inhabits salty coastal waters and estuaries ([@B4]), and some are the causative agent of cholera. Two virulence factors, cholera toxin (CT) and toxin coregulated pilus (TCP), are considered the most closely connected to cholera. CT, encoded by the *ctxAB* operon in the *V. cholerae* lysogenic phage CTXΦ, is an AB~5~ toxin that consists of a single catalytic A-subunit and a pentamer of B-subunits ([@B33]). It can enhance the concentration of intracellular cyclic AMP, which then causes an imbalance in electrolyte transport across the intestinal epithelial cell membrane, resulting in the secretion of water and electrolytes into the bowel accompanied by severe watery diarrhea, which may lead to death without timely treatment ([@B4]). TCP, the subunit of which is encoded by *tcpA* (in the *tcpABQCRDSTEF* operon), is essential for colonization of *V. cholerae* in the small intestine at the early stage of infection ([@B23]). It also functions as the receptor for the CTXΦ ([@B47]).

The expression of TCP and CT is tightly regulated by a regulatory cascade, referred to as the ToxR virulence regulon ([@B3]). Under virulence inducing growth conditions, ToxR cooperates with TcpP to bind to the promoter region of *toxT* to activate its transcription, and ToxT, in turn, activates the transcription of *ctxAB* and *tcpA* ([@B8]; [@B28]; [@B16]). ToxR alone also can directly activate *ctxAB* transcription in the presence of bile acids ([@B20]). While under non-inducing growth conditions, TcpP and ToxT are proteolytically degraded in order to terminate virulence gene expression ([@B32]; [@B1]). The genes for TCP and CT production are also regulated by quorum sensing (QS) ([@B35]; [@B59]), a cell-to-cell communication process that bacteria use to monitor their cell density by detecting the extracellular concentration of autoinducers (AIs), the signaling molecules ([@B2]). In vibrios, AphA and LuxR orthologs (referred to as the [H]{.ul}CD [m]{.ul}aster [r]{.ul}egulators, HMRs) represent the terminal master regulator of QS operating at low cell density (LCD) and high cell density (HCD), respectively ([@B31]). AphA, which has interaction with AphB, binds to the promoter of *tcpPH* to activate its transcription ([@B25]). HapR (the homologous protein of LuxR) represses the transcription of *tcpPH* via binding and repression of *aphA* transcription ([@B27]). The global regulator cAMP-CRP represses *tcpPH* transcription via its ability to influence AphA- and AphB-dependent transcriptional activation of *tcpPH*. This is because the cAMP-CRP binding site is completely within the binding sites of AphA and AphB ([@B26]). H-NS also has roles in silencing the expression of TCP and CT by binding and repression of *ctx*, *tcp*, and *toxT* promoters ([@B37]; [@B41]). In addition, the ferric uptake regulator Fur seems to have positive regulatory activity on TCP production, because deletion of *fur* repressed *tcp* transcription and exhibited very weak autoagglutination, one indicator of the capacity of *V. cholerae* infection *in vivo* ([@B34]).

Although HapR repression of TCP and CT via repression of AphA has been demonstrated, whether HapR can directly regulate the genes within the ToxR virulence regulon or not, needs to be further investigated. In addition, the mechanisms of the Fur-dependent activation of TCP expression are also unclear. Moreover, transcription of *fur* was under the direct control of HapR, and HapR coordinates with Fur to regulate *hlyA* transcription ([@B12]), suggesting Fur integrated into QS to co-regulate gene expression in *V. cholerae*.

In the present study, we showed that transcription of *tcpP*, *toxT*, and *tcpA* were all cell-density dependent, which may be due to the coordinated regulation of Fur and HapR ([Figure 1](#F1){ref-type="fig"}). At the OD~600~ value of about 0.7, Fur binds to the promoters of *tcpP*, *toxT*, and *tcpA* to activate their transcription; while at the OD~600~ value of about 1.0, the QS regulator HapR directly represses the transcription of *tcpP* and *tcpA*, but it indirectly represses *toxT* transcription. The data enriched the regulatory networks that control the expression of virulence determinants in *V. cholerae*, which promotes a deeper understanding of the pathogenic mechanisms of the pathogen.

![Regulatory model. The regulatory relationships between LuxO, Qrrs, AphA, and HapR (or its homologous protein) have been previously reported in vibrios ([@B18]; [@B46]; [@B39]; [@B43]; [@B56]). AphA and HapR are the bottom master regulators of QS operating at LCD and HCD, respectively. Fur coordinates with HapR to tightly regulate *tcpP*, *toxT*, and *tcpA*, leading to the cell density transcriptional manner of expression of these genes. HapR repression of Fur ([@B12]), AphA activation of *tcpP* ([@B26]; [@B25]), TcpP activation of *toxT* ([@B28]), autoregulation of Fur ([@B29]), and ToxT activation of *tcpA* ([@B8]) were reported by other researchers. LCD, low cell density; MCD, medium cell density; HCD, high cell density.](fmicb-11-00709-g001){#F1}

Materials and Methods {#S2}
=====================

Bacterial Strains and Cultural Conditions {#S2.SS1}
-----------------------------------------

*Vibrio cholerae* El Tor serogroup O1 strain C7258 (Peru, 1991) was used as the derivative (wild type, WT). Non-polar *fur* and *hapR* single-gene deletion mutants Δ*fur* and Δ*hapR* derived from the WT strain were constructed in our previous study ([@B12]). The deletion mutant of *lacZ* (designated as Δ*lacZ*) was constructed from WT by homologous recombination using the suicide plasmid pWM91, which was similarly performed as previously described ([@B50]). All primers used in the present work are listed in [Table 1](#T1){ref-type="table"}.

###### 

Oligonucleotide primers used in this study.

  Target                        Primers (forward/reverse, 5′--3′)
  ----------------------------- --------------------------------------------------------------------------
  **Construction of mutants**   
  *fur*                         CGGGATCCTTCGTGTAAGGCAGCAGTAATC/CAGAGCGTAAAGCCTATGGATACTTTCCTGTTGATGTTC
                                GAACATCAACAGGAAAGTATCCATAGGCTTTACGCTCTG/GGACTAGTAGATGAAGATGGTGTGGGAAAC
                                CGGGATCCTTCGTGTAAGGCAGCAGTAATC/GGACTAGTAGATGAAGATGGTGTGGGAAAC
  *hapR*                        GCGGGATCCCCAGCAATACATCTTTACC/GTGCTGCCCAAGAAAAGGGGTATATCCTTGCC
                                GGCAAGGATATACCCCTTTTCTTGGGCAGCAC/GCGACTAGTAACTCACCAAAACCTTC
                                GCGGGATCCCCAGCAATACATCTTTACC/GCGACTAGTAACTCACCAAAACCTTC
  *lacZ*                        GCGGGATCCCACGGAGGGAAGGGTAAA/CCTTAAGGCTCTCTGGCCCCTCAAGCCGAGGAGTAAAG
                                CTTTACTCCTCGGCTTGAGGGGCCAGAGAGCCTTAAGG/GGACTAGTCAGCCCAGACAGTGAAGG
                                GCGGGATCCCACGGAGGGAAGGGTAAA/GGACTAGTCAGCCCAGACAGTGAAGG
  **Protein expression**        
  *fur*                         GCGGGATCCATGTCAGACAATAACCAAG/GCGAAGCTTTTATTTCTTCGGCTTGTGAG
  *hapR*                        GCGGGATCCATGGACGCATCAATCGAAAAAC/GCGAAGCTTCTAGTTCTTATAGATACACAG
  **qPCR**                      
  *tcpP*                        GCACAAGATCCAATGAAGCC/CTGGTTCTTTTGATTGCCTGAG
  *tcpA*                        TGGTCTCAGCGGGTGTTG/CATTTGCGTTTGCGGTAGC
  *toxT*                        TTTTCAGGGTTCTTCTCG/ACAAATATCTGCCCAACG
  *toxR*                        TTTGTTTGGCGAGAGCAAGG/TCTTCTTCAACCGTTTCCACTC
  *recA*                        AAGATTGGTGTGATGTTTGGTA/CACTTCTTCGCCTTCTTTGA
  **Primer extension**          
  *tcpA*                        /CCAGAACAATGATTACTTC-HEX
  **Luminescence assay**        
  *tcpP*                        GCGGAGCTCGTGCCTGCTGAGAACTAA/GCGGGATCCCAAAGGTTATCGGGAAAT
  *tcpA*                        GCGGAGCTCTCCCGACTACTCAGAAAG/GCGGGATCCATTTATATAACTCCACC
  *toxT*                        GCGGAGCTCGTGAATGTTGGTGG/GCGGGATCCTGCGTTCTACTCTG
  *toxR*                        GCGGAGCTCTCCGCACCGTCACCGC/GCGGGATCCCTAATGTCCCAGTATC
  *fur*                         GCGGAGCTCGCATCAAGGCATAAACGG/GCGACTAGTATACTTTCCTGTTGATGTTC
  *hapR*                        GCGGAGCTCCCAGCAATACATCTTTACC/GCGACTAGTTGAGGCGATAGCCGAGTT
  **DNase I footprinting**      
  *tcpP*                        GTAAAACGACGGCCAGTCAGGAAAGATAATGTAACC/CAGGAAACAGCTATGACGTGTACCAATCAGCCTTT
                                GTAAAACGACGGCCAGTGTGCCTGCTGAGAACTAA/CAGGAAACAGCTATGACGGGCTTTTTTTAACTTTG
  *tcpA*                        GTAAAACGACGGCCAGTTCCCAATTGGTTGGCTC/CAGGAAACAGCTATGACCATATTTATATAACTCCACC
  *toxT*                        GTAAAACGACGGCCAGTCAGGTCGATTTCTTAC/CAGGAAACAGCTATGACTTCCACTATCTATCC
                                GTAAAACGACGGCCAGTCAGGTCGATTTCTTAC/CAGGAAACAGCTATGACCCTTAAACTGCACATC
  *toxR*                        GTAAAACGACGGCCAGTTCCGCACCGTCACCGC/CAGGAAACAGCTATGACCCAATATGACTCATCG
  M13                           FAM-GTAAAACGACGGCCAGT/CAGGAAACAGCTATGAC-HEX

All strains were maintained at −80°C in LB broth \[1% tryptone (Oxoid), 0.5% yeast extract (Oxoid), and 1% NaCl (Merck Millipore)\] containing 30% glycerol (v/v). Unless stated otherwise, *V*. *cholerae* strains were cultured with AKI \[1.5% Bacto peptone (BD Biosciences), 0.4% yeast extract (Oxoid), 0.5% NaCl (Merck Millipore), and 0.3% NaHCO~3~ (Merck Millipore)\] of the TCP-induced conditions as previously described ([@B22]). When appropriate, the culture medium was supplemented with 100 μg/ml ampicillin or 50 μg/ml kanamycine.

Competition Assay {#S2.SS2}
-----------------

*In vivo* competition assay was performed as previously described ([@B44]). The Δ*lacZ*, Δ*fur* and Δ*hapR* strains were grown overnight on LB agar containing the appropriate antibiotics at 37°C. For each strain approximately 10 colonies were resuspended in 1 ml phosphate-buffered saline (PBS). The strains were mixed 1:1 and adjusted to a final concentration of approximately 10^6^CFU/ml. Five-day-old CD-1 infant mice were used as the infection model, and each mouse was intragastrically inoculated with 100 μl (about 10^5^ CFU) of the mixture ([@B44]). Mice were sacrificed at 20 h post-inoculation, and the bacterial cells in the intestines were enumerated on LB agar plates containing 40 μg/ml of 5-bromo-4-chloro-3-indolyl-β-[D]{.smallcaps}-galactopyranoside (*X*-gal) to differentiate the Δ*lacZ* and the regulatory gene mutant colonies and to determine the input ratios and bacterial titers. *In vitro* competitions were performed in parallel to calculate the input ratios by inoculating 2 μl of the mix into 1 ml LB and incubating overnight at 37°C with aeration. The competition index (CI) of the input and the output were calculated as the blue/white ratio of the mutant/Δ*lacZ*.

This work was performed in strict accordance with animal protocols approved by the Ethics Committee of the National Institute for Communicable Disease Control and Prevention, China CDC.

Quantitative PCR (qPCR) {#S2.SS3}
-----------------------

Extraction of bacterial total RNAs, generation of cDNAs, and operation of qPCR were performed as previously described ([@B14]). The relative mRNA levels were determined based on the standard curve of *recA* (reference gene) expression for each RNA preparation. The qPCR assay was performed with at least three independent biological samples.

Luminescence Assay {#S2.SS4}
------------------

For the luminescence assay ([@B52]; [@B12]), the promoter DNA region of each target gene was cloned into the pBBRlux harboring a promoterless *luxCDABE* reporter gene and a chloramphenicol resistance gene. The recombinant plasmid was transferred into WT and each mutant strain, respectively. Strains transformed with recombinant plasmids were cultivated in AKI-inducing conditions and harvested at the required cell densities. The luminescence was measured using an Infinite^®^ 200 Pro NanoQuant (Tecan, Switzerland). The *lux* activity was calculated as light units/OD~600~.

DNase I Footprinting Assay {#S2.SS5}
--------------------------

The recombinant proteins His-Fur and His-HapR were expressed using the pET28a plasmid and the *Escherichia coli* BL21λDE3 cells ([@B24]; [@B15]). The purified recombinant proteins were concentrated to a final concentration of 0.3 to 0.6 mg/ml. DNase I footprinting and sequencing assays were carried out as previously described ([@B13]; [@B55]). Briefly, the FAM (or HEX)-labeled DNA probes were incubated with the increasing amounts of His-tagged protein, and digested by the optimized RQ1 RNase-Free DNase I (Promega), and then analyzed using an ABI 3500XL DNA Genetic analyzer with GeneMarker software 2.2, while the DNA sequencing products were surveyed with Sequence Scanner software v1.0.

Primer Extension Assay {#S2.SS6}
----------------------

The primer extension assay was essentially performed as previously described ([@B12]). Twelve micrograms of total RNA was annealed with 1 pmol of 5′- HEX-labeled reverse primer to generate cDNAs using the Primer Extension System (Promega), and the products of primer extension were then analyzed using the ABI 3500XL DNA Genetic analyzer.

Experimental Replicates and Statistical Methods {#S2.SS7}
-----------------------------------------------

The competition assay was done at least three independent times with similar results. The data of DNase I footprinting and primer extension were done at least two independent times. The luminescence assay and qPCR were performed with at least three independent bacterial cultures, and the values were expressed as the mean ± standard deviation (SD). Paired Student's *t-*test was used to calculate significant differences, *P* \< 0.01 was considered to indicate statistical significance.

Results {#S3}
=======

Binding Sites of HapR/Fur Were Predicted Within the Regulatory Regions of *tcpP*, *tcpA*, and *toxT* {#S3.SS1}
----------------------------------------------------------------------------------------------------

Toxin coregulated pilus production is under the control of a tightly regulated signaling cascade composed of ToxR, TcpP/H, and ToxT ([@B3]). It has been reported that HapR represses *tcpA* transcription through binding and repression of *aphA* ([@B27]), however, it remains unknown whether HapR can directly repress *tcpA* or not. Here, the 700 bp upstream regions of *toxR*, *tcpP*, *toxT*, and *tcpA* were retrieved from the genome sequence of strain C7258, and the DNA binding box of the HMRs (TATTGATAAA-TTTATCAATA) in vibrios ([@B56]) was used to statistically predict the presence of HMRs box-like sequences within the above target promoter sequences by using the *matrix-scan* tool^[1](#footnote1){ref-type="fn"}^. The higher weighted score for the target gene represented the higher probability of direct protein and DNA sequence association. With the weight score cut-off of 6.0, the HMRs box-like sequences were predicted for *tcpP* and *tcpA*, but not for *toxR* and *toxT* ([Table 2](#T2){ref-type="table"}), suggesting the possible direct binding of HapR on the promoter regions of these two genes.

###### 

Predicted HMRs/Fur box-like sequences within target promoters.

                      Fur box-like sequence   HMRs box-like sequence                                               
  ---------- -------- ----------------------- ------------------------ ----- -------------- ---------------------- -----
  *toxRS*    *toxR*   NA                      NA                       NA    NA             NA                     NA
             *toxT*   D-611...-593            AATGAAATTTATCCTCATA      8.9   NA             NA                     NA
  *tcpPH*    *tcpP*   D-459...-441            AATTATTTTTTTTATCATT      9.4   R-71...-52     TTTTAATATAATTATTTGCA   7.7
  *tcpA-F*   *tcpA*   D-273...-255            AACGCATTTTATTTGCATT      7.0   D-125...-106   AAAAATGATATCTGTCAATT   6.1

&

'D' indicates the direct sequence while 'R' the reverse one; minus numbers denote the nucleotide positions upstream of indicated genes; 'NA' represents 'not applicable.'

We considered that Fur may also possibly to regulate the expression or assembly of TCP, since the *fur* mutant exhibited reduced TCP expression and weak autoagglutination ([@B34]). In our study, the Fur binding box ([@B34]; [@B6]) was used as well for prediction of Fur box-like sequences within the promoter regions of *toxR*, *tcpP*, *toxT*, and *tcpA*. Fur box-like sequences were predicted from each promoter of *toxT*, *tcpP*, and *tcpA*, but none was detected for the *toxR* promoter ([Table 2](#T2){ref-type="table"}). Expression of Fur itself was directly and negatively regulated by HapR in *V. cholerae* ([@B12]), thus, we speculated that the transcription of *tcpP*, *toxT*, and *tcpA* might be regulated under the collective effects of HapR and Fur in a subtle manner in *V. cholerae*.

Transcription of *hapR*, *fur*, *tcpP*, *toxT*, and *tcpA* Were Cell Density-Dependent in the TCP-Induced AKI Culture Condition {#S3.SS2}
-------------------------------------------------------------------------------------------------------------------------------

A transcriptional luminescence reporter assay was applied to detect the transcriptional changes of *hapR*, *fur*, *toxR*, *tcpP*, *toxT*, and *tcpA* during the growth periods of *V. cholerae* in the TCP-induced AKI culture condition. As shown in [Figure 2](#F2){ref-type="fig"}, the transcriptional patterns of all of the genes tested were manifested in a cell-density dependent manner. The highest transcriptional levels of *hapR* and *fur* occurred at an OD~600~ value of around 1.0 and 0.7, respectively, which were consistent with that described in a previous report ([@B12]). In addition, the transcriptional levels of *tcpP/tcpA* and *toxR*/*toxT* obviously increased with the increase of cell density from 0 to 0.4 and from 0 to 0.6, respectively, and then declined with the further increase of the cell density. The bacteria cells were harvested at the OD~600~ value of about 1.0 and 0.7 for characterizing HapR- and Fur-mediated gene regulation, respectively.

![Cell density--dependent expression of target genes. The WT strain was transformed with a recombinant pBBRlux vector that contains a promoter DNA region of the target gene. The bacteria were cultivated in the TCP-induced AKI conditions to determine the luminescence activity under various OD~600~ values.](fmicb-11-00709-g002){#F2}

HapR Repressed Transcription of *tcpP* and *tcpA* Directly, and Repressed *toxT* Indirectly {#S3.SS3}
-------------------------------------------------------------------------------------------

The qPCR results showed that the mRNA transcription of *tcpP*, *toxT*, and *tcpA* were greatly increased in Δ*hapR* relative to WT ([Figure 3A](#F3){ref-type="fig"}), while that of *toxR* manifested no obvious difference between Δ*hapR* and WT ([Supplementary Figure S1A](#FS1){ref-type="supplementary-material"}). In addition, the luminescence assays showed that the promoter activities of *tcpP*, *toxT*, and *tcpA* in Δ*hapR* were much higher than that in WT ([Figure 3B](#F3){ref-type="fig"}), whereas that under the control of *toxR* promoter showed a similar magnitude in Δ*hapR* and WT ([Supplementary Figure S1B](#FS1){ref-type="supplementary-material"}). The DNase I footprinting assay disclosed that His-HapR protected a single DNA region within each of the promoters of *tcpP* and *tcpA*, located from 48 to 14 and 127 to 95 upstream of *tcpP* and *tcpA* against DNase I digestion ([Figure 3C](#F3){ref-type="fig"}), but no HapR binding sites were detected for *toxT* and *toxR* ([Figure 3C](#F3){ref-type="fig"} and [Supplementary Figure S1C](#FS1){ref-type="supplementary-material"}). Thus, HapR inhibits the transcription of *tcpP* and *tcpA* in a direct manner, but it indirectly represses *toxT* transcription and manifests no regulatory action on *toxR* transcription.

![Regulation of *tcpP*, *toxT*, and *tcpA* by HapR. **(A)** qPCR. Relative mRNA levels of the target genes were compared between Δ*hapR* and WT. **(B)** The luminescence assay was done as shown in [Figure 2](#F2){ref-type="fig"}. **(C)** DNase I footprinting. The promoter DNA fragment of each target gene was labeled with FAM and HEX, respectively, and incubated with increasing amounts of purified His-HapR (L-I, -II, and -III contain 0, 2.31, and 6.92 pmol, respectively). After being digested with DNase I, the fragments were analyzed using an ABI 3500XL DNA analyzer. The protected regions are boxed and marked with positions. The negative and positive numbers indicate the nucleotide positions relative to the translation start site (+1) of the corresponding gene.](fmicb-11-00709-g003){#F3}

Fur Directly Activates the Transcriptions of *tcpP*, *toxT*, and *tcpA* {#S3.SS4}
-----------------------------------------------------------------------

The qPCR assay was employed to investigate the regulatory effects of Fur on the transcription of *toxR*, *tcpP*, *toxT*, and *tcpA*, and the results showed that the mRNA levels of *tcpP*, *toxT*, and *tcpA* were obviously decreased in Δ*fur* relative to WT ([Figure 4A](#F4){ref-type="fig"}), while that of *toxR* manifested no obvious difference between Δ*fur* and WT ([Supplementary Figure S2A](#FS2){ref-type="supplementary-material"}). These results suggested that Fur activates the transcription of *tcpP*, *toxT*, and *tcpA*, but it seems to have no regulatory activity on *toxR* transcription. In addition, the promoter DNA region of *toxR*, *tcpP*, *toxT*, and *tcpA* was each cloned into the pBBRlux plasmid, and then transferred into Δ*fur* and WT, respectively, to test the regulatory actions of Fur on their promoter activities. The results showed that the luminescence under the control of *tcpP*, *toxT*, or *tcpA* promoter in Δ*fur* was much lower than that in WT ([Figure 4B](#F4){ref-type="fig"}), whereas that under the control of *toxR* promoter showed a similar magnitude in Δ*fur* and WT ([Supplementary Figure S2B](#FS2){ref-type="supplementary-material"}). As further determined by the DNase I footprinting assay, His-Fur protected a single DNA region within each of the promoters of *tcpP*, *toxT*, and *tcpA*, located from 524 to 446, 626 to 537, and 282 to 198 upstream of *tcpP*, *toxT*, and *tcpA* against DNase I digestion in a dose-dependent manner ([Figure 4C](#F4){ref-type="fig"}), but no binding sites were detected for *toxR* ([Supplementary Figure S2C](#FS2){ref-type="supplementary-material"}). Thus, Fur activates the transcription of *tcpP*, *toxT*, and *tcpA* in a direct manner, but has no regulatory activity on *toxR* transcription.

![Regulation of *tcpP*, *toxT*, and *tcpA* by Fur. The qPCR **(A)** and DNase I footprinting assays **(C)** were done as [Figure 3](#F3){ref-type="fig"}, while the luminescence assay **(B)** was done as [Figure 2](#F2){ref-type="fig"}. L-I, -II, and -III contain 0, 2.95, and 8.85 pmol of His-Fur, respectively.](fmicb-11-00709-g004){#F4}

Identification of the Transcription Start Site for *tcpA* {#S3.SS5}
---------------------------------------------------------

The 500 bp upstream DNA regions of *tcpP*, *toxT*, and *tcpA* in El Tor strain C7258 share a high identity (90, 99, and 87%, respectively) in nucleotide sequences with that of in classical biotype strain O395, in which the transcription start sites of these genes have been previously reported ([@B19]; [@B26]; [@B17]; [@B41]) (also seen in [Supplementary Figure S3](#FS3){ref-type="supplementary-material"}). However, it was notable that the nucleotides in the position of the transcription start site of *tcpA* are different in these two strains ([Supplementary Figure S3](#FS3){ref-type="supplementary-material"}). Thus, in this study, we mapped the transcription start site of *tcpA* using the primer extension assay. As shown in [Supplementary Figure S4](#FS4){ref-type="supplementary-material"}, the assay detected only one transcription start site for *tcpA* located at 74 bp upstream of the coding region, the position of which is exactly the same as that of in O395, suggesting that a point mutation in this position has occurred in the two strains. The −10 element is good match with the consensus prokaryotic sequence, but the −35 element is non-conservative, suggesting that *tcpA* possess a relatively weak promoter ([Figure 6](#F6){ref-type="fig"}).

Fur but Not HapR Plays a Role in Intestinal Colonization of *V. cholerae* in Infant Mice {#S3.SS6}
----------------------------------------------------------------------------------------

The *in vivo* competition assay was employed to further investigate the ability of Δ*fur* and Δ*hapR* strains to colonize the small intestine of infant mice in comparison with the Δ*lacZ* strain ([Figure 5](#F5){ref-type="fig"}). The results showed that the colonization ability of Δ*fur* was attenuated approximately 10-fold, while that of Δ*hapR* seemed to have no obvious difference compared to Δ*lacZ* (CI ≈ 1). The same extent colonization capacity of Δ*hapR* as wild-type *V. cholerae* has been previously reported ([@B59]; [@B58]). These results suggested that Fur but not HapR is required for efficient colonization.

![Infant mouse competition assay using Δ*fur*, Δ*hapR*, and Δ*lacZ* cells. The Δ*fur* and Δ*hapR* were competed against Δ*lacZ*. The competitive index is the ratio of mutant to Δ*lacZ* recovered from the intestine calculated by the ratio of input mutant to Δ*lacZ* (inoculated into the mouse). Each data point represents the competitive index from an individual mouse. The line bar represents the geometric mean. The Δ*fur* strain is significantly attenuated (*P* \< 0.01) by Student *t*-test.](fmicb-11-00709-g005){#F5}

Discussion {#S4}
==========

*Vibrio cholerae* expresses the virulence determinants to establish colonization in the gut and cause disease diarrhea. Expression of TCP and CT is highly regulated by environmental stimuli and a variety of regulators ([@B45]; [@B36]; [@B37]; [@B26]; [@B59]; [@B25]; [@B34]; [@B3]). The regulatory cascade, which is constituted of ToxR, TcpP, and ToxT referred to as the ToxR virulence regulon, has been shown to be involved in the regulation of TCP and CT, and the regulatory mechanisms also have been well documented ([@B8]; [@B28]; [@B16]). Other regulatory factors modulate TCP and CT production mostly via regulation of the genes within this cascade ([@B26]; [@B25]). HapR also has been shown to be involved in regulating the transcription of *tcpP*, *toxT*, and *tcpA* ([@B27]; [@B59]), but lacks the direct evidence for its binding to their regulatory regions.

In the present study, we found a HMRs box-like sequence for each promoter of *tcpP* and *tcpA*, suggesting that the transcription of *tcpP* and *tcpA* would be under the direct control of HapR in *V. cholerae*. We observed that HapR binds to the promoters of *tcpP* and *tcpA* to repress their transcription when the bacterial cells were harvested at an OD~600~ value of about 1.0. The HapR binding site for each *tcpP* and *tcpA* promoter overlaps the core −10 and/or −35 elements, and thus HapR repression of *tcpP* and *tcpA* transcription would be via blocking the entry or elongation of the RNA polymerase. In addition, we noticed that the HapR binding site for *tcpA* promoter partly overlaps with the sequence protected by ToxT ([@B53]; [@B49]), which acts as an activator of *tcpA*. Thus, the binding of HapR to the *tcpA* promoter may prevent ToxT from binding to. However, the binding site of HapR for *tcpP* promoter excludes the HMRs box-like sequence, suggesting the results of the informatics analysis are not always reliable. HapR also appears to repress the transcription of *toxT* in an indirect manner, which differs from its interaction with *tcpP* and *tcpA* promoters and could involve additional regulators. A previously study showed that ToxR and TcpP bind adjacently to the promoter DNA region of *toxT* ([Figure 6](#F6){ref-type="fig"}), and the interaction of ToxR and TcpP with the *toxT* promoter enhanced the ability of TcpP to interact with RNA polymerase, leading to transcriptional activation of *toxT* ([@B28]). Thus, HapR repression of *toxT* promoter may be via the directly repression of *tcpP* transcription by HapR.

![Promoter organization of target genes. The sequences were derived from *Vibrio cholerae* El Tor C7258. The transcription/translation start sites are indicated by bent arrows. The --10 and --35 elements are enclosed in boxes. The binding sites of ToxR and TcpP identified by DNase I digestion were previously reported by [@B28]. The sequence protected by ToxT in the promoter DNA region of *tcpA* was identified by [@B53] and [@B49]. The Fur sites are underlined with solid lines, whereas the HapR sites are underlined with broken lines.](fmicb-11-00709-g006){#F6}

HapR is a global regulator that controls the expression of hundreds of genes, particularly those responsible for the motility, biofilm formation, metabolism, and virulence ([@B2]). HapR regulon contains a variety of transcriptional regulator genes, such as *aphA* ([@B27]), *vpsT* ([@B48]), *qstR* ([@B30]), and *fur* ([@B12]). The regulatory actions of HapR on other regulatory genes bridge the different regulons in *V. cholerae*, forming complex regulatory networks to tightly control gene expression. For instance, HapR directly regulated the expression of Fur and HlyU, and these regulators coordinately regulated the transcription of *hlyA*, leading to the highest expression level of *hlyA* occurring at the early mid-logarithmic growth phase ([@B12]). Although the regulatory mechanisms are still obscure, Fur-dependent TCP production has been observed in *V. cholerae* ([@B34]). Thus, we deduced that expression of TCP is also coordinately regulated by HapR and Fur in *V. cholerae*.

The binding sites of Fur usually contain a 19 bp inverted repeat sequence known as the classic Fur box ([@B9]; [@B34]; [@B57]). A 21 bp palindromic sequence was also reported as the enhanced Fur box ([@B6]), but it shares sequence similarity with the previously predicted ([@B34]). The Fur box-like sequences were detected for the promoters of *toxT*, *tcpP*, and *tcpA*. Indeed, the transcription of the three above genes was under the direct and positive control of Fur at OD~600~ value of about 0.7. The Fur binding site for each target promoter located far upstream of the core −35 element. Thus, Fur activation of *toxT*, *tcpP*, and *tcpA* transcription may belong to the class I stimulation mechanism ([@B21]). However, Fur binding sites for *toxT*, *tcpP*, and *tcpA* were not identified by ChIP-seq analysis ([@B6]). Discrepancies between the present data and the data identified by ChIP-seq could be attributed to the different experimental methods, growth conditions and/or bacterial genetic background, because the ChIP-seq is used to map the binding sites of a regulator *in vivo*. Anyhow, the data presented here showed that Fur activation of TCP production is via at least direct activation of *toxT* and *tcpP* transcription, as well as the TCP coding gene *tcpA*.

Toxin coregulated pilus mostly contributes to the colonization of *V. cholerae* in the host intestine ([@B23]). We thus investigated the colonization ability of *fur* and *hapR* deletion mutants in the small intestine of an infant mouse model. The results showed that the colonization ability of Δ*fur* was significantly attenuated relative to that of the Δ*lacZ* strain, which was consistent with previous report ([@B34]). Fur is an iron-dependent transcriptional regulator that regulates the expression of multitudinous genes involved in iron homeostasis, virulence, biofilm formation, ribosome formation, transporters, porin proteins, and unique sRNAs ([@B38]; [@B7]; [@B34]; [@B51]; [@B5]; [@B6]; [@B42]). Iron is an essential metallic element for life, but there is almost no free iron to use within the intestine of humans at the early infection stage of *V. cholerae* ([@B11]). It was reported that the stools from cholera patients contain a heterogenous mixture of biofilm-like aggregates, and the biofilm formation is initiated almost immediately after adherence of *V. cholerae* to intestinal cells ([@B10]; [@B40]). Our unpublished data showed that Δ*fur* produces more biofilms than the WT strain under the iron-starved growth condition. The attenuated colonization ability of Δ*fur* could be attributed to the significantly enhanced biofilm formation and the low production of TCP. The ability of colonization of Δ*hapR* showed no obvious difference compared to that of the Δ*lacZ* strain, the same as previously reported ([@B59]). However, the Δ*hapR* strain showed a 10-fold colonization defect relative to the WT strain, when used as the inoculum composed of biofilms to infect infant mice ([@B58]). The Δ*hapR* strains formed much thicker biofilms, but the detachment of Δ*hapR* from biofilms was defective, which may influence the HapR-dependent colonization in biofilms ([@B58]). In a word, Fur-dependent but HapR-independent colonization in planktonic cells would be beneficial to the pathogenesis and transmission of *V. cholerae* during the disease progression.

The highest expression levels of *tcpP*, *toxT*, and *tcpA* occurred at an OD~600~ value of around 0.4, but the lower expression levels were observed at both LCD and HCD. AphA is the bottom master regulator of QS that operates at LCD ([@B31]). However, a previous study showed that AphA binds to the promoter of *tcpPH* to activate its transcription ([@B25]). TcpP, in turn, activates *toxT* and *tcpA* transcription ([@B8]; [@B28]). Thus, we deduced that: at LCD or at the initial stage of infection, AphA activates the expression of TCP and CT via direct activation of *tcpP* expression, which promotes colonization and induces watery diarrhea. However, the intracellular level of AphA protein is rapidly degraded with the increase of cell density ([@B39]). At this point, Fur may be engaged to further activate the expression of TCP through binding and activation of the transcription of *tcpP*, *toxT*, and *tcpA*. While at HCD or at the later stage of infection (high number of *V. cholerae* cells in the intestine), high expressed HapR binds to the promoters of *tcpP* and *tcpA* to repress their transcription, and thus inhibits TCP and CT production, which then enables the pathogen to detach from the epithelium, and exits the host along with the stool. In addition, the transcriptional pattern of *toxR* also manifested a cell-density dependent manner, with a similar results previously observed in *V. cholerae* and the closely related *Vibrio parahaemolyticus* ([@B52]; [@B54]). However, both HapR and Fur seemed to have no regulatory actions on *toxR* transcription under the current growth conditions. The molecular mechanism of cell-density dependent expression of *toxR*, therefore, needs to be further investigated. Nevertheless, the present work enriched the virulence regulatory networks in *V. cholerae*, and broadens our understanding of the pathogenic mechanisms of the pathogen.
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###### 

Regulation of *toxR* by HapR. The qPCR **(A)** and DNase I footprinting assays were done as in [Figure 3](#F3){ref-type="fig"}, while the luminescence assay **(B)** was done as in [Figure 2](#F2){ref-type="fig"}. L-I, -II, and -III contain 0, 2.31, and 6.92 pmol of His-HapR, respectively.
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Click here for additional data file.

###### 

Regulation of *toxR* by Fur. The qPCR **(A)** and DNase I footprinting assays were done as [Figure 3](#F3){ref-type="fig"}, while the luminescence assay **(B)** was done as in [Figure 2](#F2){ref-type="fig"}. L-I, -II, and -III contain 0, 2.95, and 8.85 pmol of His-Fur, respectively.
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###### 

The nucleotide sequences alignment of the promoter DNA regions of *tcpP* and *toxT*. The promoter DNA sequences of *tcpP*, *toxT* and *tcpA* were derived from *V. cholerae* El Tor biotype strain C7258 and classical biotype strain O395. The different bases were labeledred, while the identical bases were marked with asterisk (\*). Shown also were the transcription start sites, -10 and -35 boxes.
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Transcription start site of *tcpA* in *V. cholerae* El Tor biotype strain C7258. A 5′-HEX-labeled reverse primer was designed to be complementary to the RNA transcript of *tcpA*. The primer extension products were analyzed with an ABI 3500XL DNA Genetic analyzer. The transcription start site was marked with asterisks andpositions.
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